AstraZeneca shares owned by Kathmere Capital Management
Quarter-by-quarter ownership of AstraZeneca (AZN) shares owned by Kathmere Capital Management
from 13F filings
Historical chart of Kathmere Capital Management investment in AstraZeneca
Tip: Access up to 7 years of quarterly data
All positions including AstraZeneca held by Kathmere Capital Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in AstraZeneca by Kathmere Capital Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-12-31 | $331k | 5.1k | 65.52 |
| 2024-09-30 | $485k | 6.2k | 77.91 |
| 2024-06-30 | $262k | 3.9k | 67.35 |
| 2024-03-31 | $275k | 4.1k | 67.75 |
| 2023-12-31 | $262k | 3.9k | 67.35 |
| 2023-09-30 | $348k | 5.1k | 67.72 |
| 2023-06-30 | $347k | 4.9k | 71.57 |
| 2023-03-31 | $312k | 4.5k | 69.41 |
| 2022-12-31 | $300k | 4.4k | 67.80 |
| 2022-09-30 | $240k | 4.4k | 54.92 |
| 2022-06-30 | $317k | 4.8k | 66.11 |
| 2022-03-31 | $356k | 5.4k | 66.42 |
| 2021-09-30 | $242k | 4.0k | 60.08 |
| 2020-12-31 | $81k | 1.6k | 50.28 |
| 2020-09-30 | $88k | 1.6k | 54.62 |
More positions owned by Kathmere Capital Management
View all positions for Kathmere Capital Management